DTL
RVNC

Dynamic Technology Lab’s Revance Therapeutics, Inc. RVNC Stock Holding History

Dynamic Technology Lab’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,001
Closed -$88K – 1429
2024
Q3 		$88K Buy
+17,001
New +$84.5K 0.01% 944
2024
Q1 		– Sell
-27,370
Closed -$240K – 1501
2023
Q4 		$240K Buy
+27,370
New +$224K 0.03% 825
2023
Q2 		– Sell
-6,840
Closed -$220K – 1491
2023
Q1 		$220K Sell
6,840
-27,349
-80% -$853K 0.02% 882
2022
Q4 		$631K Buy
+34,189
New +$782K 0.06% 505
2018
Q2 		– Sell
-22,847
Closed -$704K – 1384
2018
Q1 		$704K Buy
+22,847
New +$735K 0.1% 341

Other funds holding RVNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dynamic Technology Lab's RVNC Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2024, closing a stake of 17,001 shares — an estimated $88K sold.

Dynamic Technology Lab first reported a position in RVNC in Q1 2018 and held it in 5 quarters. The position peaked at $704K in Q1 2018. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Revance Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,001 Revance Therapeutics, Inc. shares in Q4 2024, an estimated $88K.
  • Dynamic Technology Lab first reported a position in Revance Therapeutics, Inc. in Q1 2018 and held it in 5 quarters.
  • Dynamic Technology Lab's Revance Therapeutics, Inc. position peaked at $704K in Q1 2018.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.